drugset / Trial / NCT01925937

Atorvastatin/CoenzymeQ10 in Congestive Heart Failure

NCT01925937

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to compare the effect of addition of combination of Atorvastatin/CoenzymeQ10 to standard congestive heart failure (CHF) treatment versus addition of Atorvastatin alone on CHF outcomes.

Timeline

Start
2013-06
Primary completion
2014-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Coenzyme Q10 Other / unclassified 100 mg
Background Atorvastatin Small molecule 10 mg